Process for treating an individual with an esthetic defect of skin by modulating SASPase FLG2 complex
US9869681B2 · kind B2 · utility
0Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 2011 |
| Grant date | Jan 16, 2018 |
| Priority date | — |
| Expiry date | Oct 19, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of a compound, suitable for modulating the interaction between first and second partner proteins, or between homologues, mutants, or fragments of said proteins, said first and second proteins being SASPase and filaggrin-2, or FLG2, as an active agent for treating and/or preventing aesthetic defects in the skin, and/or in the appendages thereof, linked to an imbalance in the differentiation and/or proliferation of the cells of the epidermis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.